forgopro.com.ua, Ltd. | Online Annual Report 2018 Roche Group

Why not explore our latest Annual Report?

This Annual Report uses integrated reporting to show where the company is now, and where it is going. Its in-depth and comprehensive nature might seem challenging, but we invite investors and other stakeholders to take some time to browse through the pages.
Here, we briefly describe the key topics of Annual Report 2018 and introduce its contents and a few highlights.

What’s in the report

What kind of company are we?

Many people may not be familiar with Chugai. In the “About Us” section, we explain what sets Chugai apart from other companies, what we value, and the other characteristics that make Chugai unique. In “Messages from Management,” members of our management team talk about how they plan to lead the company into the future.

Chugai is attracting quite a bit of interest from various people, including healthcare professionals and investors. For a quick overview of the company, I recommend looking at ‘Chugai’s Strengths.’

About Us

  • Mission Statement
  • Financial Performance and Chugai’s Strengths
  • The History of Chugai
Download PDF

What are we aiming for?

To evaluate a company’s prospects, it is important to know where it is heading. What exactly is the “advanced and sustainable patient-centric healthcare” that Chugai envisions? What kind of society does Chugai want to help create? The answers, and the background to these questions, are presented here.

Healthcare is expected to change dramatically going forward. With that in mind, the section “Value Shared with Stakeholders” summarizes the various kinds of value we are trying to create with each of our stakeholders. We hope you can feel a connection with some of them.

Chugai’s Value Creation

  • Our Approach to Value Creation
  • Value Shared with Stakeholders
  • Will: What We Will Do
  • Must: What We Must Do
  • Can: What We Can Do
  • Process for Establishing Material Issues
Download PDF

How will we achieve it?

To bring about its Envisioned Future and survive, Chugai must continue to innovate and evolve. In “Chugai’s Growth Strategies,” we explain specifically what we will do. The key, of course, is “innovation.”

The explanation of the mid-term business plan includes comments from executives and employees to give a sense of the atmosphere in the Company. Is Chugai a company that can grow? Can I count on it? What do you think?

Chugai’s Growth Strategies

  • Previous Mid-Term Business Plans
  • Context of the Formulation of IBI 21
  • Overview of New Mid-Term Business Plan IBI 21
  • Strategy 1: Value Creation
  • Strategy 2: Value Delivery
  • Strategy 3: Promote Advances in PHC
  • Strategy 4: Strengthen Human Capital and Conduct Fundamental Structural Reform
  • Strategy 5: Strengthen Sustainable Platforms
  • Message from the CFO
Download PDF

For more information, click here

Highlights

Download
  • Financial and Pre-Financial Highlights

Corporate Governance

Download
  • Message from the Chairman
  • Messages from Directors
  • Corporate Governance
  • Board of Directors, Audit & Supervisory Board and Executive Committee Members

Chugai in Action

Download
  • Overview of Activities in 2018
  • Research
  • Development
  • Pharmaceutical Technology and Production
  • Marketing
  • Medical Affairs
  • Drug Safety/Quality and Regulatory Compliance
  • Intellectual Property
  • Human Resources
  • Human Rights
  • Environment, Health and Safety
  • Social Contribution
  • Corporate Communications

Data Section

Download
  • Basic Information
  • 9-Year Financial Summary
  • Management’s Discussion and Analysis
  • Consolidated Financial Statements
  • Independent Auditor’s Report
  • Glossary
  • Network
  • Shareholder Information
  • Corporate Overview

[ Annual Report Contents ]

  • About Us
    • Mission Statement
    • Financial Performance and Chugai’s Strengths
    • The History of Chugai
  • Messages from Management
    • Message from the CEO
    • Message from the Deputy Chairman
  • Chugai’s Value Creation
    • Our Approach to Value Creation
    • Value Shared with Stakeholders
    • Will: What We Will Do
    • Must: What We Must Do
    • Can: What We Can Do
    • Process for Establishing Material Issues
  • Highlights
    • Financial and Pre-Financial Highlights
  • Chugai’s Growth Strategies
    • Previous Mid-Term Business Plans
    • Context of the Formulation of IBI 21
    • Overview of New Mid-Term Business Plan IBI 21
    • Strategy 1: Value Creation
    • Strategy 2: Value Delivery
    • Strategy 3: Promote Advances in PHC
    • Strategy 4: Strengthen Human Capital and Conduct Fundamental Structural Reform
    • Strategy 5: Strengthen Sustainable Platforms
    • Message from the CFO
  • Corporate Governance
    • Message from the Chairman
    • Messages from Directors
    • Corporate Governance
    • Board of Directors, Audit & Supervisory Board and Executive Committee Members
  • Chugai in Action
    • Overview of Activities in 2018
    • Research
    • Development
    • Pharmaceutical Technology and Production
    • Marketing
    • Medical Affairs
    • Drug Safety/Quality and Regulatory Compliance
    • Intellectual Property
    • Human Resources
    • Human Rights
    • Environment, Health and Safety
    • Social Contribution
    • Corporate Communications
  • Data Section
    • Basic Information
    • 9-Year Financial Summary
    • Management’s Discussion and Analysis
    • Consolidated Financial Statements
    • Independent Auditor’s Report
    • Glossary
    • Network
    • Shareholder Information
    • Corporate Overview
силденафил цена

steroids-king.com/golden-dragon-euro-prime-farmaceuticals.html

buysteroidsgroup.net/aromatase-blockers/tamoxifen/
Back to top